Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Bausch Lomb Corporation (BLCO.TO)

Bausch Lomb Corporation (BLCO.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 10,078,934
  • Shares Outstanding, K 352,164
  • Annual Sales, $ 4,146 M
  • Annual Income, $ -260,000 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales 1.50
  • Price/Cash Flow 32.14
  • Price/Book 1.10
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -1.04
  • Most Recent Earnings $0.01 on 10/30/24
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Medical Instruments & Suppls

Price Performance

See More
Period Period Low Period High Performance
1-Month
24.49 +13.35%
on 10/08/24
29.37 -5.48%
on 10/15/24
+1.99 (+7.72%)
since 10/04/24
3-Month
21.00 +32.19%
on 09/13/24
29.37 -5.48%
on 10/15/24
+5.26 (+23.38%)
since 08/02/24
52-Week
18.11 +53.29%
on 05/02/24
29.37 -5.48%
on 10/15/24
+4.27 (+18.18%)
since 11/03/23

Most Recent Stories

More News
Stocks in play: Bausch + Lomb Corporation

Announced its second-quarter 2024 financial results. Total reported revenue was $1.216 billion for the ...

BLCO.TO : 27.76 (-3.00%)
Stocks in play: Bausch + Lomb Corporation

Announced the U.S. launch of Blink NutriTears, a clinically proven over-the-counter supplement that ...

BLCO.TO : 27.76 (-3.00%)
Stocks in play: Bausch + Lomb Corporation

Announced its ONE by ONE and Biotrue® Eye Care Recycling programs have collected 84,343,540 units, or ...

BLCO.TO : 27.76 (-3.00%)
Stocks in play: Bausch + Lomb Corporation

Today announced 15 podium and four poster presentations during the American Society of Cataract and ...

BLCO.TO : 27.76 (-3.00%)
Stocks in play: Bausch + Lomb Corporation

Announced its fourth-quarter 2023 financial results. Revenue of $1.173 Billion. GAAP Net Loss Attributable ...

BLCO.TO : 27.76 (-3.00%)
Stocks in play: Bausch + Lomb Corporation

Today announced three podium presentations and seven poster presentations during the American Academy ...

BLCO.TO : 27.76 (-3.00%)
Stocks in play: Bausch + Lomb Corporation

Announced the U.S. launch of LUMIFY EYE ILLUMINATIONS, a new line of hypoallergenic specialty eye care ...

BLCO.TO : 27.76 (-3.00%)
Stocks in play: Bausch + Lomb Corporation

Announced its ONE by ONE and Biotrue Eye Care Recycling programs have been recognized as 2023 Sustainability ...

BLCO.TO : 27.76 (-3.00%)
Stocks in play: Bausch + Lomb Corporation

Announced the U.S. commercial launch of MIEBO (perfluorohexyloctane ophthalmic solution) for the treatment ...

BLCO.TO : 27.76 (-3.00%)
Stocks in play: Bausch + Lomb Corporation

Today announced that Chairman and CEO Brent Saunders is scheduled to participate at the 2023 Wells Fargo ...

BLCO.TO : 27.76 (-3.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed...

See More

Key Turning Points

3rd Resistance Point 29.55
2nd Resistance Point 29.07
1st Resistance Point 28.42
Last Price 27.76
1st Support Level 27.29
2nd Support Level 26.81
3rd Support Level 26.16

See More

52-Week High 29.37
Last Price 27.76
Fibonacci 61.8% 25.07
Fibonacci 50% 23.74
Fibonacci 38.2% 22.41
52-Week Low 18.11

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar